ABOUT THE AUTHOR
I have a PhD in bio-medical anthropology became bored with Academia and repackaged my problem-solving skills to become an expert in pharmaceutical New Product Planning and Strategic Marketing that led to becoming Senior Vice President of Global Strategy for one of the top Swiss Pharma companies. In my professional role, I developed a strong interest in personalized medicine and a passion for its implementation. I was involved in a pharmaceutical company’s acquisition of a diagnostics group in the late 1990’s to accelerate implementation of personalized medicine. Recently, I wrote a business plan for the implementation of personalized medicine for a G7 country.
I’m a native of Berkeley, California, and live there today. I got my BA in anthropology from the University of California and went on to graduate school at the University of Pennsylvania, which I thought was another state school. Budding anthropologists have to choose where to do fieldwork. In my case, I looked for the amalgam of beaches, tropics, and French food. I won my personal trifecta in the then New Hebrides (now Vanuatu). I was fortunate to study with the discoverer of the hepatitis B virus.
The Goldilocks Genome
COMING IN JANUARY 2023 FROM TOUCHPOINT PRESS
THE GOLDILOCKS GENOME is a science-based medical thriller about Jonas Von Gelden, a psychopathic serial killer seeking to avenge the death of his wife Wendy, whose prescription for an anti-depressant leads to her suicide.
The title refers to what happens when a drug meets a gene. Genes are the blueprints for the enzymes that metabolize drugs. Drugs are “just right” for about 40% of patients and “too much” or “too little” for the remainder. Outside of the Goldilocks zone, the results can be fatal.
Wendy’s suicide sets off a cascade of events leading to random deaths of an increasing number of people who are being treated with selective serotonin reuptake inhibitors (SSRIs).
The heroine is Carrie Hediger, the Director of the San Francisco district of the FDA, an epidemiologist whose best friend is one of the random victims. Convinced her friend has been poisoned, the heroine hones in on the murderer using statistics, persuasion, persistence, and disregard of the rules to trap him.
The novel reflects Elizabeth's interests and skills. She has a doctorate in biomedical anthropology. She lived on Malo Island in Vanuatu for two years, where she developed her problem-solving epidemiology tools to investigate why some infants became chronic carriers of hepatitis B virus and not others. After a brief stint in Academia, she went into New Product Development in the pharmaceutical industry, where she became Senior Vice President of Global Strategy for one of the top Swiss Pharma companies.
Twenty-five years ago, Elizabeth understood the promise of individual genotyping to tailor prescriptions. Popular fiction is a great way to educate people and push demand for better prescribing tools. The more people understand the benefits of personalized medicine versus today’s empirical “one size fits all” prescribing algorithm, the faster it will be implemented, and the better will be the quality of our healthcare.
More to Come
“I just finished your book. You write well, captivating. I am impressed. I love it when I know just enough about the writer that she appears in and out of the story. You probably know Carrie well...I love how you are introducing genomics, and bringing that to light. It’s an excellent book. Congratulation. When is the next one coming out?”
More to Come